Activities of taurolidine in vitro and in experimental enterococcal endocarditis.
about
Taurolidine lock solutions for the prevention of catheter-related bloodstream infections: a systematic review and meta-analysis of randomized controlled trialsTaurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patientsAntibiotic and other lock treatments for tunnelled central venous catheter-related infections in children with cancerTaurolidine antiadhesive properties on interaction with E. coli; its transformation in biological environment and interaction with bacteria cell wallCentral venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin.New antibiotic agents and approaches to treat biofilm-associated infections.Bench-to-bedside review: Challenges of diagnosis, care and prevention of central catheter-related bloodstream infections in childrenAntimicrobial activity of a novel catheter lock solution.Taurolidine susceptibility of methicillin-resistant Staphylococcus pseudintermedius isolates.The promise of novel technology for the prevention of intravascular device-related bloodstream infection. II. Long-term devices.Comparative in vitro efficacies of various catheter lock solutions.Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution.Intravitreal taurolidine against experimental Staphylococcus epidermidis endophthalmitis in rabbits.Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin
P2860
Q21132431-B4FCBD73-3FDA-43C4-BF25-CE90A11187F5Q21261533-98D95870-2B2E-4DEC-9B16-93FD82D6D3ECQ24201815-67FF86FC-CA51-430B-8F0F-6B80E515EBA4Q33529088-2A84D6F4-8907-4F19-9A6A-97BBF848B4B4Q34328275-8EFA6130-EF65-43D9-BE83-C1500412E1EEQ37773364-8EE01FBB-DA77-4D3D-8B2E-2CC6F173D9EEQ38138178-AEC1165E-2624-41D6-A791-97446FE61AE0Q39652091-BF801F2D-082E-4D5C-BB06-BCEE037BF26CQ40115375-03A4C3A6-B4E4-42B3-BF6F-97D4C01C6C4FQ40643660-17F7BE2F-A489-4FAD-B145-B57040EBEA23Q42424787-51178333-6885-4CF0-B680-4A4ECE105CD9Q44475708-AD609452-E066-409A-98EA-9C417306FFADQ44982991-6DE81621-A87E-4911-AC36-11891742DCF4Q46417164-EF50A402-5D0B-4213-A206-4ADE429F2E76Q58456007-94C4E367-8697-4120-878C-3B377A615D55
P2860
Activities of taurolidine in vitro and in experimental enterococcal endocarditis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Activities of taurolidine in vitro and in experimental enterococcal endocarditis.
@ast
Activities of taurolidine in vitro and in experimental enterococcal endocarditis.
@en
type
label
Activities of taurolidine in vitro and in experimental enterococcal endocarditis.
@ast
Activities of taurolidine in vitro and in experimental enterococcal endocarditis.
@en
prefLabel
Activities of taurolidine in vitro and in experimental enterococcal endocarditis.
@ast
Activities of taurolidine in vitro and in experimental enterococcal endocarditis.
@en
P2093
P2860
P1476
Activities of taurolidine in vitro and in experimental enterococcal endocarditis.
@en
P2093
C B Wennersten
C Thauvin-Eliopoulos
C Torres-Viera
G M Eliopoulos
M G Farris
P DeGirolami
P2860
P304
P356
10.1128/AAC.44.6.1720-1724.2000
P407
P577
2000-06-01T00:00:00Z